The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
- March 18, 2024
Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.
- March 11, 2024Source: Yale Medicine
The FDA’s approval of Wegovy could help millions of Americans with both obesity and cardiovascular disease lower their risk of having a major cardiac event.
- February 26, 2024Source: NBC Connecticut
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology and metabolism), has been leading pivotal trials to test anti-obesity medications.
- February 05, 2024
In a Q&A, Ania Jastreboff, MD, PhD, discusses the barriers to treating obesity, benefits of clinical trials, and the new era of obesity medicine.
- January 19, 2024Source: Today
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology), talks about the decreased hunger patients may experience when taking Ozempic or Wegovy.
- January 12, 2024Source: WTNH Channel 8
Ania Jastreboff, MD, PhD, Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management, is interviewed by WTNH-TV on muscle loss while losing weight.
- December 18, 2023Source: Healio
Many anti-obesity medications are currently in phase 3 trials. Adults with obesity can achieve 15% or more weight loss with multiple anti-obesity medications in the pipeline.
- December 15, 2023Source: Medscape
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology), is one of the leading experts on a six-part series discussing the science behind the obesity epidemic.
- December 14, 2023Source: Hartford Courant
Kevan Herold, MD, C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology), and Jennifer Sherr, MD, PhD, professor in pediatrics (endocrinology), discuss a new drug for type 1 diabetes.